✦ LIBER ✦

Early vascular and metabolic effects of rosuvastatin compared with simvastatin in patients with type 2 diabetes

✍ Scribed by Alfonso Bellia; Stefano Rizza; Angelica Galli; Rossella Fabiano; Giulia Donadel; Marco Felice Lombardo; Carmine Cardillo; Paolo Sbraccia; Manfredi Tesauro; Davide Lauro

Book ID: 118422858
Publisher: Elsevier Science
Year: 2010
Tongue: English
Weight: 119 KB
Volume: 210
Category: Article
ISSN: 0021-9150
DOI: 10.1016/j.atherosclerosis.2009.11.021

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

[7] A COMPARISON BETWEEN METABOLIC AND V

[7] A COMPARISON BETWEEN METABOLIC AND VASCULAR EFFECTS OF SIMVASTATIN AND ROSUVASTATIN IN PATIENTS WITH TYPE 2 DIABETES

✍ A. Bellia; A. Galli; S. Rizza; R. Fabiano; M. Tesauro; M.F. Lombardo; M. Federic 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 54 KB

12 VASCULAR AND METABOLIC ACUTE EFFECTS

12 VASCULAR AND METABOLIC ACUTE EFFECTS OF ROSUVASTATIN COMPARED TO SIMVASTATIN IN UNTREATED DYSLIPIDEMIC DIABETIC PATIENTS

✍ A. Bellia; S. Rizza; A. Galli; R. Fabiano; R. Rossi; M. Federici; P. Sbraccia; D 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Cholesterol-lowering effects of rosuvast

Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes – CORALL study

✍ B. H. R. WOLFFENBUTTEL; A. A. M. FRANKEN; H. H. VINCENT; THE DUTCH CORALL STUDY 📂 Article 📅 2005 🏛 John Wiley and Sons 🌐 English ⚖ 111 KB

M.513 Cholesterol-lowering effects of ro

M.513 Cholesterol-lowering effects of rosuvastatin compared with atorvastatin in patients with type 2 diabetes

✍ Franken, A.; Wolffenbuttel, B.; Vincent, H. 📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 138 KB

Lipid-Altering Efficacy of Ezetimibe/Sim

Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20mg Compared with Rosuvastatin 10mg in High-Risk Patients with and Without Type 2 Diabetes Mellitus

✍ Jennifer Rotonda 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 96 KB

Lipid-Altering Efficacy of Ezetimibe/Sim

Lipid-Altering Efficacy of Ezetimibe/Simvastatin 10/20mg Compared with Rosuvastatin 10mg in High-Risk Patients with and Without Type 2 Diabetes Mellitus (T2DM)

✍ Philippe Brudi; Helena Vaverkova; Michel Farnier; Maurizio Averna; Margus Viigim 📂 Article 📅 2009 🏛 Elsevier 🌐 English ⚖ 96 KB